Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls
出版年份 2014 全文链接
标题
Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls
作者
关键词
Physicians, Cancer treatment, Melanomas, Palliative care, Adverse reactions, Oncology, Health care providers, Quality of life
出版物
PLoS One
Volume 9, Issue 11, Pages e111237
出版商
Public Library of Science (PLoS)
发表日期
2014-11-05
DOI
10.1371/journal.pone.0111237
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Melanoma Resistance: A Bright Future for Academicians and a Challenge for Patient Advocates
- (2014) Andrzej T. Slominski et al. MAYO CLINIC PROCEEDINGS
- Preference weights for chemotherapy side effects from the perspective of women with breast cancer
- (2013) I. Kuchuk et al. BREAST CANCER RESEARCH AND TREATMENT
- Economic burden of cancer across the European Union: a population-based cost analysis
- (2013) Ramon Luengo-Fernandez et al. LANCET ONCOLOGY
- "Well, I Think There Is Great Variation...": A Qualitative Study of Oncologists' Experiences and Views Regarding Medical Criteria and Other Factors Relevant to Treatment Decisions in Advanced Cancer
- (2013) J. Schildmann et al. ONCOLOGIST
- The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
- (2013) Caroline J. Voskens et al. PLoS One
- CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
- (2012) P. A. Prieto et al. CLINICAL CANCER RESEARCH
- How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer Therapies
- (2012) Darius N. Lakdawalla et al. HEALTH AFFAIRS
- Expression of the vitamin D–activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression
- (2012) Anna A. Brożyna et al. HUMAN PATHOLOGY
- Patients’ preferences for treatment outcomes for advanced non-small cell lung cancer: A conjoint analysis
- (2012) John F.P. Bridges et al. LUNG CANCER
- Ipilimumab in advanced melanoma
- (2012) Alberto Farolfi et al. MELANOMA RESEARCH
- Support of cancer patients' spiritual needs and associations with medical care costs at the end of life
- (2011) Tracy Balboni et al. CANCER
- Releasing the Brake on the Immune System: Ipilimumab in Melanoma and Other Tumors
- (2011) Ahmad Tarhini et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Expression of vitamin D receptor decreases during progression of pigmented skin lesions
- (2011) Anna A. Brożyna et al. HUMAN PATHOLOGY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Religious coping and behavioral disengagement: opposing influences on advance care planning and receipt of intensive care near death
- (2011) Paul K. Maciejewski et al. PSYCHO-ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Patient Age on Management Decisions in Breast Cancer: Consensus from a National Consultation
- (2010) R. C. Leonard et al. ONCOLOGIST
- How Should We Define Value in Cancer Care?
- (2010) S. Ramsey et al. ONCOLOGIST
- Of Value: A Discussion of Cost, Communication, and Evidence to Improve Cancer Care
- (2010) A. Schickedanz ONCOLOGIST
- Uncertainty in Assessing Value of Oncology Treatments
- (2010) C. D. Mullins et al. ONCOLOGIST
- How Does Older Age Influence Oncologists' Cancer Management?
- (2010) J. A. Foster et al. ONCOLOGIST
- Religious Coping and Use of Intensive Life-Prolonging Care Near Death in Patients With Advanced Cancer
- (2009) Andrea C. Phelps JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion Question
- (2009) T. Fojo et al. JNCI-Journal of the National Cancer Institute
- Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy
- (2008) Anna A. Brożyna et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells
- (2008) Andrzej Slominski et al. INTERNATIONAL JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now